Cargando…

The IMMENSE Study: The Interplay Between iMMune and ENdothelial Cells in Mediating Cardiovascular Risk in Systemic Lupus Erythematosus

Patients with systemic lupus erythematosus (SLE) have a significant increase in cardiovascular (CV) risk although they display a preserved number of circulating angiogenic CD3(+)CD31(+)CXCR4(+) T cells (T(ang)), a subpopulation of T cells which promotes repair of damaged endothelium. This happens du...

Descripción completa

Detalles Bibliográficos
Autores principales: Bortoluzzi, Alessandra, Chighizola, Cecilia Beatrice, Fredi, Micaela, Raschi, Elena, Bodio, Caterina, Privitera, Daniela, Gonelli, Arianna, Silvagni, Ettore, Govoni, Marcello, Cavazzana, Ilaria, Airò, Paolo, Meroni, Pier Luigi, Tincani, Angela, Franceschini, Franco, Piantoni, Silvia, Casciano, Fabio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7658008/
https://www.ncbi.nlm.nih.gov/pubmed/33193356
http://dx.doi.org/10.3389/fimmu.2020.572876
_version_ 1783608582841827328
author Bortoluzzi, Alessandra
Chighizola, Cecilia Beatrice
Fredi, Micaela
Raschi, Elena
Bodio, Caterina
Privitera, Daniela
Gonelli, Arianna
Silvagni, Ettore
Govoni, Marcello
Cavazzana, Ilaria
Airò, Paolo
Meroni, Pier Luigi
Tincani, Angela
Franceschini, Franco
Piantoni, Silvia
Casciano, Fabio
author_facet Bortoluzzi, Alessandra
Chighizola, Cecilia Beatrice
Fredi, Micaela
Raschi, Elena
Bodio, Caterina
Privitera, Daniela
Gonelli, Arianna
Silvagni, Ettore
Govoni, Marcello
Cavazzana, Ilaria
Airò, Paolo
Meroni, Pier Luigi
Tincani, Angela
Franceschini, Franco
Piantoni, Silvia
Casciano, Fabio
author_sort Bortoluzzi, Alessandra
collection PubMed
description Patients with systemic lupus erythematosus (SLE) have a significant increase in cardiovascular (CV) risk although they display a preserved number of circulating angiogenic CD3(+)CD31(+)CXCR4(+) T cells (T(ang)), a subpopulation of T cells which promotes repair of damaged endothelium. This happens due to the concomitant expansion of a T(ang) subset with immunosenescent features, such as the loss of CD28. Therefore, the aim of this study was to elucidate the interplay between T(ang) subpopulations and endothelial cells in a group of young SLE patients without previous cardiovascular events. Twenty SLE female patients and 10 healthy controls (HCs) were recruited. Flow cytometric analysis of endothelial progenitor cells (EPCs) and T(ang) subsets were performed and serum levels of interleukin (IL)-6, -8, matrix metalloproteinase (MMP)-9 and interferon (IFN)-γ were measured. Human umbilical vein endothelial cells (HUVECs) proliferation and pro-inflammatory phenotype in response to subjects’ serum stimulation were also evaluated. Results showed that the percentage of T(ang) and EPC subsets was reduced in SLE patients compared with HCs, with a marked increase of senescent CD28(null) cells among T(ang) subset. SLE disease activity index-2000 (SLEDAI-2K) was inversed related to T(ang) cells percentage. Furthermore, IL-8 serum levels were directly correlated with the percentage of T(ang) and inversely related to the CD28(null) T(ang) subsets. We indirectly evaluated the role of the T(ang) subset on the endothelium upon stimulation with serum from subjects with a low percentage of T(ang) CD3(+) cells in HUVECs. HUVECs displayed pro-inflammatory phenotype with up-regulation of mRNA for IL-6, intercellular adhesion molecule (ICAM)-1 and endothelial leukocyte adhesion molecule (ELAM)-1. Cell proliferation rate was directly related to IL-8 serum levels and EPC percentage. In highly selected young SLE patients without previous CV events, we found that the deterioration of T(ang) compartment is an early event in disease course, preceding the development of an overt cardiovascular disease and potentially mediated by SLE-specific mechanisms. The overcome of the CD28(null) subset exerts detrimental role over the T(ang) phenotype, where T(ang) could exert an anti-inflammatory effect on endothelial cells and might orchestrate via IL-8 the function of EPCs, ultimately modulating endothelial proliferation rate.
format Online
Article
Text
id pubmed-7658008
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-76580082020-11-13 The IMMENSE Study: The Interplay Between iMMune and ENdothelial Cells in Mediating Cardiovascular Risk in Systemic Lupus Erythematosus Bortoluzzi, Alessandra Chighizola, Cecilia Beatrice Fredi, Micaela Raschi, Elena Bodio, Caterina Privitera, Daniela Gonelli, Arianna Silvagni, Ettore Govoni, Marcello Cavazzana, Ilaria Airò, Paolo Meroni, Pier Luigi Tincani, Angela Franceschini, Franco Piantoni, Silvia Casciano, Fabio Front Immunol Immunology Patients with systemic lupus erythematosus (SLE) have a significant increase in cardiovascular (CV) risk although they display a preserved number of circulating angiogenic CD3(+)CD31(+)CXCR4(+) T cells (T(ang)), a subpopulation of T cells which promotes repair of damaged endothelium. This happens due to the concomitant expansion of a T(ang) subset with immunosenescent features, such as the loss of CD28. Therefore, the aim of this study was to elucidate the interplay between T(ang) subpopulations and endothelial cells in a group of young SLE patients without previous cardiovascular events. Twenty SLE female patients and 10 healthy controls (HCs) were recruited. Flow cytometric analysis of endothelial progenitor cells (EPCs) and T(ang) subsets were performed and serum levels of interleukin (IL)-6, -8, matrix metalloproteinase (MMP)-9 and interferon (IFN)-γ were measured. Human umbilical vein endothelial cells (HUVECs) proliferation and pro-inflammatory phenotype in response to subjects’ serum stimulation were also evaluated. Results showed that the percentage of T(ang) and EPC subsets was reduced in SLE patients compared with HCs, with a marked increase of senescent CD28(null) cells among T(ang) subset. SLE disease activity index-2000 (SLEDAI-2K) was inversed related to T(ang) cells percentage. Furthermore, IL-8 serum levels were directly correlated with the percentage of T(ang) and inversely related to the CD28(null) T(ang) subsets. We indirectly evaluated the role of the T(ang) subset on the endothelium upon stimulation with serum from subjects with a low percentage of T(ang) CD3(+) cells in HUVECs. HUVECs displayed pro-inflammatory phenotype with up-regulation of mRNA for IL-6, intercellular adhesion molecule (ICAM)-1 and endothelial leukocyte adhesion molecule (ELAM)-1. Cell proliferation rate was directly related to IL-8 serum levels and EPC percentage. In highly selected young SLE patients without previous CV events, we found that the deterioration of T(ang) compartment is an early event in disease course, preceding the development of an overt cardiovascular disease and potentially mediated by SLE-specific mechanisms. The overcome of the CD28(null) subset exerts detrimental role over the T(ang) phenotype, where T(ang) could exert an anti-inflammatory effect on endothelial cells and might orchestrate via IL-8 the function of EPCs, ultimately modulating endothelial proliferation rate. Frontiers Media S.A. 2020-10-29 /pmc/articles/PMC7658008/ /pubmed/33193356 http://dx.doi.org/10.3389/fimmu.2020.572876 Text en Copyright © 2020 Bortoluzzi, Chighizola, Fredi, Raschi, Bodio, Privitera, Gonelli, Silvagni, Govoni, Cavazzana, Airò, Meroni, Tincani, Franceschini, Piantoni and Casciano http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Bortoluzzi, Alessandra
Chighizola, Cecilia Beatrice
Fredi, Micaela
Raschi, Elena
Bodio, Caterina
Privitera, Daniela
Gonelli, Arianna
Silvagni, Ettore
Govoni, Marcello
Cavazzana, Ilaria
Airò, Paolo
Meroni, Pier Luigi
Tincani, Angela
Franceschini, Franco
Piantoni, Silvia
Casciano, Fabio
The IMMENSE Study: The Interplay Between iMMune and ENdothelial Cells in Mediating Cardiovascular Risk in Systemic Lupus Erythematosus
title The IMMENSE Study: The Interplay Between iMMune and ENdothelial Cells in Mediating Cardiovascular Risk in Systemic Lupus Erythematosus
title_full The IMMENSE Study: The Interplay Between iMMune and ENdothelial Cells in Mediating Cardiovascular Risk in Systemic Lupus Erythematosus
title_fullStr The IMMENSE Study: The Interplay Between iMMune and ENdothelial Cells in Mediating Cardiovascular Risk in Systemic Lupus Erythematosus
title_full_unstemmed The IMMENSE Study: The Interplay Between iMMune and ENdothelial Cells in Mediating Cardiovascular Risk in Systemic Lupus Erythematosus
title_short The IMMENSE Study: The Interplay Between iMMune and ENdothelial Cells in Mediating Cardiovascular Risk in Systemic Lupus Erythematosus
title_sort immense study: the interplay between immune and endothelial cells in mediating cardiovascular risk in systemic lupus erythematosus
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7658008/
https://www.ncbi.nlm.nih.gov/pubmed/33193356
http://dx.doi.org/10.3389/fimmu.2020.572876
work_keys_str_mv AT bortoluzzialessandra theimmensestudytheinterplaybetweenimmuneandendothelialcellsinmediatingcardiovascularriskinsystemiclupuserythematosus
AT chighizolaceciliabeatrice theimmensestudytheinterplaybetweenimmuneandendothelialcellsinmediatingcardiovascularriskinsystemiclupuserythematosus
AT fredimicaela theimmensestudytheinterplaybetweenimmuneandendothelialcellsinmediatingcardiovascularriskinsystemiclupuserythematosus
AT raschielena theimmensestudytheinterplaybetweenimmuneandendothelialcellsinmediatingcardiovascularriskinsystemiclupuserythematosus
AT bodiocaterina theimmensestudytheinterplaybetweenimmuneandendothelialcellsinmediatingcardiovascularriskinsystemiclupuserythematosus
AT priviteradaniela theimmensestudytheinterplaybetweenimmuneandendothelialcellsinmediatingcardiovascularriskinsystemiclupuserythematosus
AT gonelliarianna theimmensestudytheinterplaybetweenimmuneandendothelialcellsinmediatingcardiovascularriskinsystemiclupuserythematosus
AT silvagniettore theimmensestudytheinterplaybetweenimmuneandendothelialcellsinmediatingcardiovascularriskinsystemiclupuserythematosus
AT govonimarcello theimmensestudytheinterplaybetweenimmuneandendothelialcellsinmediatingcardiovascularriskinsystemiclupuserythematosus
AT cavazzanailaria theimmensestudytheinterplaybetweenimmuneandendothelialcellsinmediatingcardiovascularriskinsystemiclupuserythematosus
AT airopaolo theimmensestudytheinterplaybetweenimmuneandendothelialcellsinmediatingcardiovascularriskinsystemiclupuserythematosus
AT meronipierluigi theimmensestudytheinterplaybetweenimmuneandendothelialcellsinmediatingcardiovascularriskinsystemiclupuserythematosus
AT tincaniangela theimmensestudytheinterplaybetweenimmuneandendothelialcellsinmediatingcardiovascularriskinsystemiclupuserythematosus
AT franceschinifranco theimmensestudytheinterplaybetweenimmuneandendothelialcellsinmediatingcardiovascularriskinsystemiclupuserythematosus
AT piantonisilvia theimmensestudytheinterplaybetweenimmuneandendothelialcellsinmediatingcardiovascularriskinsystemiclupuserythematosus
AT cascianofabio theimmensestudytheinterplaybetweenimmuneandendothelialcellsinmediatingcardiovascularriskinsystemiclupuserythematosus
AT bortoluzzialessandra immensestudytheinterplaybetweenimmuneandendothelialcellsinmediatingcardiovascularriskinsystemiclupuserythematosus
AT chighizolaceciliabeatrice immensestudytheinterplaybetweenimmuneandendothelialcellsinmediatingcardiovascularriskinsystemiclupuserythematosus
AT fredimicaela immensestudytheinterplaybetweenimmuneandendothelialcellsinmediatingcardiovascularriskinsystemiclupuserythematosus
AT raschielena immensestudytheinterplaybetweenimmuneandendothelialcellsinmediatingcardiovascularriskinsystemiclupuserythematosus
AT bodiocaterina immensestudytheinterplaybetweenimmuneandendothelialcellsinmediatingcardiovascularriskinsystemiclupuserythematosus
AT priviteradaniela immensestudytheinterplaybetweenimmuneandendothelialcellsinmediatingcardiovascularriskinsystemiclupuserythematosus
AT gonelliarianna immensestudytheinterplaybetweenimmuneandendothelialcellsinmediatingcardiovascularriskinsystemiclupuserythematosus
AT silvagniettore immensestudytheinterplaybetweenimmuneandendothelialcellsinmediatingcardiovascularriskinsystemiclupuserythematosus
AT govonimarcello immensestudytheinterplaybetweenimmuneandendothelialcellsinmediatingcardiovascularriskinsystemiclupuserythematosus
AT cavazzanailaria immensestudytheinterplaybetweenimmuneandendothelialcellsinmediatingcardiovascularriskinsystemiclupuserythematosus
AT airopaolo immensestudytheinterplaybetweenimmuneandendothelialcellsinmediatingcardiovascularriskinsystemiclupuserythematosus
AT meronipierluigi immensestudytheinterplaybetweenimmuneandendothelialcellsinmediatingcardiovascularriskinsystemiclupuserythematosus
AT tincaniangela immensestudytheinterplaybetweenimmuneandendothelialcellsinmediatingcardiovascularriskinsystemiclupuserythematosus
AT franceschinifranco immensestudytheinterplaybetweenimmuneandendothelialcellsinmediatingcardiovascularriskinsystemiclupuserythematosus
AT piantonisilvia immensestudytheinterplaybetweenimmuneandendothelialcellsinmediatingcardiovascularriskinsystemiclupuserythematosus
AT cascianofabio immensestudytheinterplaybetweenimmuneandendothelialcellsinmediatingcardiovascularriskinsystemiclupuserythematosus